arrow
Y

Yohei Funakoshi

Kobe University
H指数:18
被引数:1,873

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer

一项关于纳武利尤单抗治疗铂类耐药的复发性或转移性唾液腺癌患者的II期临床试验

2025-12-010
OA
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization

AXL通过调控免疫抑制性巨噬细胞极化促进炎性乳腺癌进展

2025-05-060
OA
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody

紫杉醇联合两周一次的西妥昔单抗治疗先前接受铂类化疗和anti-PD-1抗体治疗的复发或转移性头颈癌患者的II期试验

2024-06-014
OAAI
ASO Visual Abstract: The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases
2023-07-120
PRE
The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases
2023-06-294
PRE
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
2023-01-064
OAAI
A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

异基因造血干细胞移植患者的第三剂量新型冠状病毒肺炎疫苗接种

2022-10-2911
OAAI
The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation

日本患者异基因干细胞移植后BNT162b2 mRNA新型冠状病毒肺炎疫苗的安全性和免疫原性

2022-01-2113
OAAI